Literature DB >> 22415858

Limitations of patient-associated co-morbidity model in predicting postoperative morbidity and mortality in pancreatic operations.

Rupen Shah1, Vic Velanovich, Zeeshan Syed, Andrew Swartz, Ilan Rubinfeld.   

Abstract

BACKGROUND: Patient-associated co-morbidities are a potential cause of postoperative complications. The National Surgical Quality Improvement Project (NSQIP) collects data on patient outcomes to provide risk-adjusted outcomes data to participating hospitals. However, operations which may have a high distribution of technically-related complications, such as pancreatic operations, may not be adequately assessed using such predictive models.
METHODS: A combined data set of NSQIP Public Use files (PUF) from 2005 to 2008 was created. Using this database, multiple logistic regression analyses were used to generate a predictive model of 30-day postoperative morbidity and mortality for pancreatic operations and all other operations recorded in NSQIP. Receiver-operator characteristic curves were generated and the area under those curves (AUROC) used to generate a c-statistic to assess the model's discriminatory ability. Observed-to-expected (O/E) ratios of for mortality and morbidity using not only patient-associated co-morbidities, but operation-associated information, such as work relative-value units and Current Procedural Terminology codes, were generated. Data were analyzed in SPSS.
RESULTS: In the 4-year period analyzed, there were 7,097 complex pancreatic procedures done which were compared to 568,371 procedures that were not. For postoperative mortality, the AUROC was less for pancreatic operations (0.741) compared to all other operation (0.947) and all other inpatient operations (0.927). Similarly for postoperative morbidity, the AUROC was less for pancreatic operations (0.598) compared to all other operations (0.764) and all other inpatient operations (0.817). However, the O/E ratios were similar in both groups for mortality (all other operations, 0.94 vs. pancreatic operations, 0.92) and morbidity (0.98 for both).
CONCLUSIONS: These data imply that the factors used to assess postoperative mortality and morbidity may not completely explain postoperative outcomes in pancreatic operations. These procedures are technically demanding and can have morbidities not related to pre-existing co-morbid conditions; therefore, preoperative prediction based on pre-existing co-morbidities may have limitations in these types of operations.

Entities:  

Mesh:

Year:  2012        PMID: 22415858     DOI: 10.1007/s11605-012-1857-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection.

Authors:  Bellal Joseph; John M Morton; Tina Hernandez-Boussard; Ilan Rubinfeld; Chadi Faraj; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2009-04       Impact factor: 6.113

Review 3.  Blueprint for a new American College of Surgeons: National Surgical Quality Improvement Program.

Authors:  John D Birkmeyer; David M Shahian; Justin B Dimick; Samuel R G Finlayson; David R Flum; Clifford Y Ko; Bruce Lee Hall
Journal:  J Am Coll Surg       Date:  2008-09-19       Impact factor: 6.113

4.  How do (and why should) I use the National Surgical Quality Improvement Program?

Authors:  Leigh Neumayer
Journal:  Am J Surg       Date:  2009-11       Impact factor: 2.565

5.  Using procedural codes to supplement risk adjustment: a nonparametric learning approach.

Authors:  Zeeshan Syed; Ilan Rubinfeld; Joe H Patton; Jennifer Ritz; Jack Jordan; Andrea Doud; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2011-04-13       Impact factor: 6.113

6.  Adherence to surgical care improvement project measures and the association with postoperative infections.

Authors:  Jonah J Stulberg; Conor P Delaney; Duncan V Neuhauser; David C Aron; Pingfu Fu; Siran M Koroukian
Journal:  JAMA       Date:  2010-06-23       Impact factor: 56.272

Review 7.  Preoperative evaluation of the patient with pulmonary disease.

Authors:  Srinivas R Bapoje; Julia Feliz Whitaker; Tara Schulz; Eugene S Chu; Richard K Albert
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

8.  Prioritizing quality improvement in general surgery.

Authors:  Peter L Schilling; Justin B Dimick; John D Birkmeyer
Journal:  J Am Coll Surg       Date:  2008-07-21       Impact factor: 6.113

Review 9.  An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Authors:  Alexander Stojadinovic; Ari Brooks; Axel Hoos; David P Jaques; Kevin C Conlon; Murray F Brennan
Journal:  J Am Coll Surg       Date:  2003-06       Impact factor: 6.113

Review 10.  Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index.

Authors:  Meredith K Ford; W Scott Beattie; Duminda N Wijeysundera
Journal:  Ann Intern Med       Date:  2010-01-05       Impact factor: 25.391

View more
  5 in total

1.  Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.

Authors:  Minji Jang; Hyung Woo Park; Jimi Huh; Jong Hwa Lee; Yoong Ki Jeong; Yang Won Nah; Jisuk Park; Kyung Won Kim
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

2.  Frailty predicts morbidity, complications, and mortality in patients undergoing complex abdominal wall reconstruction.

Authors:  W J Joseph; N G Cuccolo; M E Baron; I Chow; E H Beers
Journal:  Hernia       Date:  2019-09-18       Impact factor: 4.739

3.  Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia.

Authors:  Neda Amini; Gaya Spolverato; Rohan Gupta; Georgios A Margonis; Yuhree Kim; Doris Wagner; Neda Rezaee; Matthew J Weiss; Christopher L Wolfgang; Martin M Makary; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-04-30       Impact factor: 3.452

4.  Optimizing risk-adjusted outcome measures: a moving target. Invited commentary on: Variability of NSQIP assessed surgical quality based on age and disease process.

Authors:  Marquita R Decker; David Y Greenblatt
Journal:  J Surg Res       Date:  2013-02-21       Impact factor: 2.192

5.  Modified frailty index predicts complications and death after non-bariatric gastrectomies.

Authors:  Konstantinos A Zorbas; Vic Velanovich; Nestor F Esnaola; Andreas Karachristos
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.